All In MedTech

Device type · PGQ

Cochlear Implant With Combined Electrical Stimulation And Acoustic Amplification

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about PGQ: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

FDA's data service is rate-limiting requests. Try again in a minute. The numbers below may be missing or incomplete.

Product code

PGQ

Ear, Nose & Throat

Device class

Class III

FDA decisions since 2015

0

510(k), De Novo and PMA

Adverse event reports

0

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Cochlear Implant With Combined Electrical Stimulation And Acoustic Amplification
Product code
PGQ
Device class
Class III
Review panel
Ear, Nose & Throat

Latest FDA decisions

All decisions for PGQ

No 510(k), De Novo or PMA decisions for this product code since 2015.

Reports received

0

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

0

Injury reports

0

Death reports

0

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor

No reports to chart for this view.

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

No manufacturers to rank.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

No device problems coded.

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

No patient problems coded.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls for this product code in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.